Company intelligence / Profile preview
Wuhan BJM Pharm
- Ownership
- Private
- Development stage
- Commercial
Overview
Wuhan BJM Pharm specializes in the R&D and manufacturing of pharmaceutical intermediates and active pharmaceutical ingredients. The company supplies high-purity compounds used in the production of various small-molecule drugs. It holds several patents related to chemical synthesis processes but does not conduct clinical trials itself.
- Therapeutic areas
- PulmonologyCardiovascularEndocrinologyWomen's Health
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Wuhan BJM Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wuhan BJM Pharm.